The city of San Francisco’s opioid trial begins next week against two drug companies and one pharmacy after a fourth defendant reached a $10 million settlement Wednesday.
San Francisco City Attorney David Chiu, at a press conference Wednesday, announced that drug manufacturer Endo had reached an agreement. But a bench trial before U.S. District Senior Judge Charles Breyer is set to begin in San Francisco against manufacturer Teva and its distributor subsidiary Anda, AbbVie Inc.’s Allergan and Walgreen’s.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]